An international research team uncovered differences in both host and parasite gene expression between uncomplicated and severe malaria cases in The Gambia.
The Economist reports that new labs aim to centralize genetic engineering lab work.
The company is collaborating with two UK institutes to assess whether its Signatera ctDNA technology can detect disease recurrence in women treated for breast cancer.
A number of these loci were linked to blood pressure medication targets, and the researchers developed a genetic risk score.
Imperial College London researchers are working on gene drives for mosquitos to fight malaria, NPR reports.
By overlaying epilepsy genetic data onto co-expressed gene networks from post-mortem brain samples, researchers proposed a 320-gene expression network for epilepsy.
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
Using absolute and relative gene expression analyses, researchers identified expression patterns associated with preeclampsia in dozens of placental tissue samples.
Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.
They will use the funds to develop software tools for designing and testing site-specific CRISPR systems that target drug resistance mechanisms in cancer cells.
Cancer researcher Alan Rabson has died at 92, the New York Times reports.
As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.
In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.
The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.